Pee Cee Cosma

  • Market Cap: Micro Cap
  • Industry: FMCG
  • ISIN: INE417E01010
  • NSEID:
  • BSEID: 524136
INR
422.30
-5.75 (-1.34%)
BSENSE

Sep 01, 03:30 PM

BSE+NSE Vol: 940

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

940 (-23.59%) Volume

Shareholding (Jun 2026)

FII

0.00%

Held by 0 FIIs

DII

0.00%

Held by 0 DIIs

Promoter

72.58%

Why is Pee Cee Cosma Sope Ltd falling/rising?

02-Sep-2026

As of 01-Sep, the stock price of Pee Cee Cosma Sope Ltd is declining, currently at 422.30, reflecting a 1.34% decrease. This trend is marked by four consecutive days of losses and a significant drop in investor participation, indicating short-term weakness despite being above longer-term moving averages.

As of 01-Sep, the stock price of Pee Cee Cosma Sope Ltd is falling, currently at 422.30, which reflects a decrease of 5.75 or 1.34%. This decline is part of a broader trend, as the stock has been underperforming, having lost value for four consecutive days, resulting in a total drop of 4.45% during this period. Additionally, the stock has underperformed its sector by 1.49% today.<BR><BR>Investor participation appears to be decreasing, as evidenced by a significant drop in delivery volume, which fell by 63.71% compared to the 5-day average. Despite the stock being above its 20-day, 50-day, 100-day, and 200-day moving averages, it is currently below its 5-day moving average, indicating a short-term weakness. Overall, these factors contribute to the stock's current downward movement.

View full answer

Who are in the management team of Pee Cee Cosma?

01-Sep-2026

The management team of Pee Cee Cosma includes Mayank Jain (Chairman & Wholetime Director), Ankur Jain (Managing Director), Ankit Jain (Whole-time Director), Nidhi Agarwal (Company Secretary), and several Independent Directors: Nemi Chandra Jain, Anil Gupta, Babita Agarwal, and K Agarwal. This diverse team provides strong leadership and oversight for the company.

The management team of Pee Cee Cosma includes the following individuals:<BR><BR>1. **Mayank Jain** - Chairman & Wholetime Director<BR>2. **Ankur Jain** - Managing Director<BR>3. **Ankit Jain** - Whole-time Director<BR>4. **Nidhi Agarwal** - Company Secretary & Compliance Officer<BR>5. **Nemi Chandra Jain** - Independent Director<BR>6. **Anil Gupta** - Independent Director<BR>7. **Babita Agarwal** - Independent Director<BR>8. **K Agarwal** - Independent Director<BR><BR>This team brings a mix of leadership and independent oversight to the company. If you have any more questions about Pee Cee Cosma or its management, feel free to ask!

View full answer

What does Pee Cee Cosma do?

01-Sep-2026

Pee Cee Cosma Sope Ltd manufactures laundry soap and detergent powder in the FMCG sector, with a market cap of INR 114 Cr and reported net sales of 49 Cr and net profit of 3 Cr for June 2026. The company has a P/E ratio of 13.00 and a dividend yield of 0.70%.

Overview:<BR>Pee Cee Cosma Sope Ltd is engaged in the manufacturing of laundry soap, detergent powder, and cake, operating within the FMCG industry and classified as a micro-cap company.<BR><BR>History:<BR>The company was incorporated in November 1986 by a private Indian party and became a public limited company in 1989. The latest quarterly results reported net sales and profit for June 2026.<BR><BR>Financial Snapshot:<BR>Net Sales: 49 Cr (Quarterly Results - Jun 2026)<BR>Net Profit: 3 Cr (Quarterly Results - Jun 2026)<BR>Market Cap: INR 114 Cr (Micro Cap)<BR><BR>Key Metrics:<BR>P/E: 13.00<BR>Industry P/E: 44<BR>Dividend Yield: 0.70%<BR>Debt Equity: -0.38<BR>Return on Equity: 14.88%<BR>Price to Book: 2.02<BR><BR>Contact Details:<BR>Address: Padam Deep 5th Floor, G-10/8 Sanjay Place Agra Uttar Pradesh : 282002<BR>Tel: 91-0562-2527332<BR>Email: pccosmalisting@doctorsoap.com<BR>Website: http://www.peeceecosma.com

View full answer

Who are the peers of the Pee Cee Cosma?

01-Sep-2026

Pee Cee Cosma's peers include Aayush Wellness, Vistar Amar, Leo Dryfruits, and others, with varying management risks and growth rates. Vistar Amar leads in 1-year returns at 58.03%, while Pee Cee Cosma has a return of -6.01%.

Peers: The peers of Pee Cee Cosma are Aayush Wellness, Vistar Amar, Leo Dryfruits, B & A, Modern Dairies, Thrive Future Ha, Grob Tea Co, Norben Tea, Ganges Securitie, and Jeyyam Global.<BR><BR>Quality Snapshot: Excellent management risk is observed at Aayush Wellness, Leo Dryfruits, and Modern Dairies, while Good management risk is found at Pee Cee Cosma and the rest. Average management risk is present at Vistar Amar, B & A, Grob Tea Co, Norben Tea, and Jeyyam Global, while Below Average management risk is noted at Thrive Future Ha and Ganges Securitie. Growth is Excellent at Vistar Amar and Leo Dryfruits, while Good growth is seen at Aayush Wellness and Modern Dairies, and Below Average growth is observed at Pee Cee Cosma, B & A, Thrive Future Ha, Grob Tea Co, Norben Tea, Ganges Securitie, and Jeyyam Global. Capital Structure is Excellent at Pee Cee Cosma, Modern Dairies, and Ganges Securitie, while Good capital structure is noted at Aayush Wellness and Leo Dryfruits, Average at B & A, and Below Average at Thrive Future Ha, Grob Tea Co, Norben Tea, and Jeyyam Global.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Vistar Amar at 58.03%, while the lowest is Aayush Wellness at -61.84%. Pee Cee Cosma's 1-year return is -6.01%, which is better than Aayush Wellness but worse than Vistar Amar. Additionally, the six-month return is negative for B & A, Modern Dairies, Thrive Future Ha, and Ganges Securitie.

View full answer

How big is Pee Cee Cosma?

01-Sep-2026

As of 31st August, Pee Cee Cosma Sope Ltd has a market capitalization of 114.00 Cr, with Net Sales of 167.30 Cr and a Net Profit of 8.69 Cr reported in the latest four quarters.

As of 31st August, Pee Cee Cosma Sope Ltd has a market capitalization of 114.00 Cr, categorizing it as a Micro Cap company.<BR><BR>In the latest four quarters, the company reported Net Sales of 167.30 Cr and a Net Profit of 8.69 Cr.<BR><BR>The latest annual period for the balance sheet is March 2025, with Shareholder's Funds amounting to 48.57 Cr and Total Assets of 57.39 Cr.

View full answer

Should I buy, sell or hold Pee Cee Cosma Sope Ltd?

29-Aug-2026

Are Pee Cee Cosma Sope Ltd latest results good or bad?

12-Aug-2026

Pee Cee Cosma Sope Ltd's latest results show strong sales growth with record net sales of ₹43.36 crores, but a significant net profit decline of 68.65% raises concerns about operational efficiency, leading to a "STRONG SELL" rating from the market.

Pee Cee Cosma Sope Ltd's latest results present a mixed picture. On one hand, the company achieved record net sales of ₹43.36 crores in Q4 FY26, which reflects a solid year-on-year growth of 19.81% and a sequential increase of 3.19%. This indicates strong demand for its products in the market.<BR><BR>However, the net profit for the same quarter was ₹0.95 crores, which represents a significant decline of 68.65% compared to the previous quarter. While the net profit shows a year-on-year improvement of 48.44%, the sharp drop sequentially raises concerns about the company's operational efficiency and margin sustainability. The operating margin also contracted to 7.38%, down from 9.78% in the prior quarter, indicating increased cost pressures.<BR><BR>Overall, while the sales growth is a positive sign, the drastic profit decline and margin compression suggest that the company is facing significant operational challenges. This combination of strong revenue growth but weak profitability points to underlying issues that investors should be cautious about. The stock's technical position is bearish, and the overall investment score indicates a "STRONG SELL" rating, reflecting the market's concerns about the company's future performance.

View full answer

When is the next results date for Pee Cee Cosma Sope Ltd?

05-Aug-2026

The next results date for Pee Cee Cosma Sope Ltd is 12 August 2026.

The next results date for Pee Cee Cosma Sope Ltd is scheduled for 12 August 2026.

View full answer

Is Pee Cee Cosma overvalued or undervalued?

05-Dec-2025

As of December 4, 2025, Pee Cee Cosma is fairly valued with a PE ratio of 12.79 and an EV to EBITDA of 8.03, especially when compared to overvalued peers like Hindustan Unilever and Nestle India, despite its year-to-date stock performance lagging at -34.46% against the Sensex's 9.12%.

As of 4 December 2025, the valuation grade for Pee Cee Cosma has moved from attractive to fair, indicating a shift in market perception. The company is currently fairly valued based on its financial metrics. Key ratios include a PE ratio of 12.79, an EV to EBITDA of 8.03, and a ROE of 15.16%. <BR><BR>In comparison to its peers, Pee Cee Cosma's valuation stands out against Hindustan Unilever, which has a PE ratio of 54.69, and Nestle India, with a PE of 80. This suggests that while Pee Cee Cosma is fairly valued, its peers are significantly overvalued. Additionally, the company's recent stock performance has lagged behind the Sensex, with a year-to-date return of -34.46% compared to the Sensex's 9.12%, reinforcing the notion of a fair valuation amidst a challenging market environment.

View full answer

How has been the historical performance of Pee Cee Cosma?

13-Nov-2025

Pee Cee Cosma's historical performance shows mixed results, with net sales increasing to 144.34 crore but a decline in operating profit and profit after tax, reflecting challenges in profitability despite growth in sales and total assets. Cash flow from operations also decreased, indicating further financial difficulties.

Answer:<BR>The historical performance of Pee Cee Cosma shows a mixed trend in financial metrics over the past year.<BR><BR>Breakdown:<BR>In the fiscal year ending March 2025, Pee Cee Cosma reported net sales of 144.34 crore, an increase from 133.64 crore in March 2024. However, total operating income remained the same as net sales, with no other operating income reported. The raw material cost rose significantly to 104.84 crore from 90.30 crore, contributing to a total expenditure of 131.30 crore, up from 118.29 crore the previous year. Consequently, the operating profit (PBDIT) decreased to 14.81 crore from 15.95 crore, reflecting a decline in the operating profit margin from 11.49% to 9.03%. Profit before tax also fell to 12.94 crore from 14.05 crore, leading to a profit after tax of 9.64 crore, down from 10.44 crore, resulting in a PAT margin decrease from 7.81% to 6.68%. On the balance sheet, total assets increased to 57.39 crore from 47.84 crore, while total liabilities also rose to 57.39 crore, up from 47.84 crore. The book value per share improved to 183.54 from 152.23. Cash flow from operating activities decreased to 7.00 crore from 10.00 crore, and the net cash inflow/outflow remained at 0.00 crore for the last two years. Overall, while sales and total assets showed growth, profitability metrics and cash flow from operations indicated challenges for the company.

View full answer

How has been the historical performance of Pee Cee Cosma?

12-Nov-2025

Pee Cee Cosma's historical performance shows increased net sales and total assets, but declines in operating profit, profit before tax, and cash flow from operations over the past year. Overall, while sales growth is evident, profitability has decreased.

Answer:<BR>The historical performance of Pee Cee Cosma shows a mixed trend in its financial metrics over the past year.<BR><BR>Breakdown:<BR>In the fiscal year ending March 2025, Pee Cee Cosma reported net sales of 144.34 Cr, an increase from 133.64 Cr in March 2024. The total operating income also rose to 144.34 Cr from 133.64 Cr, while total expenditure increased to 131.30 Cr from 118.29 Cr. The operating profit (PBDIT) excluding other income decreased to 13.04 Cr from 15.35 Cr, leading to an overall operating profit of 14.81 Cr, down from 15.95 Cr. Profit before tax fell to 12.94 Cr from 14.05 Cr, and profit after tax decreased to 9.64 Cr from 10.44 Cr. The earnings per share (EPS) also declined to 36.38 from 39.4. On the balance sheet, total assets increased to 57.39 Cr from 47.84 Cr, with total liabilities rising to 57.39 Cr from 47.84 Cr. The book value per share adjusted rose to 183.54 from 152.23. Cash flow from operating activities decreased to 7.00 Cr from 10.00 Cr, while cash flow from investing activities remained stable at -5.00 Cr. Overall, the financial performance indicates growth in sales and assets but a decline in profitability and cash flow from operations.

View full answer

Who are the top shareholders of the Pee Cee Cosma?

17-Jul-2025

The top shareholder of Pee Cee Cosma is Ankit Jain, holding 9.44%, with individual investors collectively owning 20.67%. There are no pledged promoter holdings, mutual funds, or foreign institutional investors involved.

The top shareholders of Pee Cee Cosma primarily consist of promoters, with Ankit Jain being the individual with the highest holding at 9.44%. There are no pledged promoter holdings, and the company does not have any mutual funds or foreign institutional investors (FIIs) holding shares. Additionally, individual investors collectively hold 20.67% of the shares. There are no significant public shareholders listed.

View full answer

What is the technical trend for Pee Cee Cosma?

09-Jun-2025

As of May 23, 2025, Pee Cee Cosma's trend has shifted to bearish with moderate strength, driven by bearish indicators like the MACD and moving averages, despite some bullish momentum in the RSI.

As of 23 May 2025, the technical trend for Pee Cee Cosma has changed from mildly bearish to bearish. The current stance is bearish with moderate strength. Key indicators driving this include a bearish MACD on the weekly chart, bearish moving averages on the daily chart, and a bearish KST on the weekly chart. The Bollinger Bands also indicate a mildly bearish trend on both weekly and monthly time frames. The RSI shows bullish momentum on the weekly, but this is overshadowed by the overall bearish signals. The Dow Theory indicates no trend on both weekly and monthly time frames, suggesting a lack of directional conviction.

View full answer

Has Pee Cee Cosma declared dividend?

06-Jun-2025

Yes, Pee Cee Cosma Sope Ltd has declared a 30% dividend, amounting to ₹3 per share, with an ex-date of September 20, 2024. While recent returns show volatility, the company has demonstrated strong long-term growth, particularly in price appreciation.

Pee Cee Cosma Sope Ltd has declared a 30% dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 30%<BR>- Amount per share: 3<BR>- Ex-date: 20 Sep 24<BR><BR>Dividend Yield: 1.03%.<BR><BR>Total Returns by Period:<BR>In the last 6 months, the price return was -26.73%, with a dividend return of 0%, resulting in a total return of -26.73%.<BR><BR>Over the past year, the price return was 18.52%, the dividend return was 0.69%, leading to a total return of 19.21%.<BR><BR>In the 2-year period, the price return was 134.15%, the dividend return was 2.48%, culminating in a total return of 136.63%.<BR><BR>For the 3-year period, the price return was 342.05%, with a dividend return of 5.66%, resulting in a total return of 347.71%.<BR><BR>In the last 4 years, the price return was 213.67%, the dividend return was 5.68%, leading to a total return of 219.35%.<BR><BR>Over the past 5 years, the price return was 503.07%, with a dividend return of 11.79%, resulting in a total return of 514.86%.<BR><BR>Overall, Pee Cee Cosma has declared a significant dividend, and while the recent returns over shorter periods show volatility, the longer-term returns indicate strong growth, particularly in price appreciation.

View full answer
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

1

Poor long term growth as Net Sales has grown by an annual rate of 14.70% and Operating profit at 17.07% over the last 5 years

 
2

Falling Participation by Institutional Investors

3

Underperformed the market in the last 1 year

stock-summaryMojo Parameters

Mojo Parameters

Loading Valuation Snapshot...

Stock DNA

stock-summary
Industry

FMCG

stock-summary
Market cap

INR 113 Cr (Micro Cap)

stock-summary
P/E

13.00

stock-summary
Industry P/E

44

stock-summary
Dividend Yield

0.70%

stock-summary
Debt Equity

-0.38

stock-summary
Return on Equity

14.88%

stock-summary
Price to Book

2.02

Revenue and Profits:
Net Sales:
49 Cr
(Quarterly Results - Jun 2026)
Net Profit:
3 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0.7%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
32.13%
0%
32.13%
6 Months
21.46%
0%
21.46%
1 Year
-9.1%
0.65%
-8.45%
2 Years
-28.19%
1.02%
-27.17%
3 Years
29.64%
2.35%
31.99%
4 Years
274.38%
7.11%
281.49%
5 Years
197.39%
6.29%
203.68%

Latest dividend: 3 per share ex-dividend date: Sep-19-2025

Risk Adjusted Returns v/s stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryNews & Corporate Actions

News

Announcements stock-summary

Announcement under Regulation 30 (LODR)-Newspaper Publication

17-Aug-2026 | Source : BSE

publication of unaudited results for quarter ended 30th June 2026 in Newspaper

Board Meeting Outcome for BOARD MEETING OUTCOME

12-Aug-2026 | Source : BSE

BOARD MEETING OUTCOME:

Unaudited Financial Results For The Quarter Ended 30Th June 2026

12-Aug-2026 | Source : BSE

unaudited financial results for the quarter ended 30th June 2026

Corporate Actions stock-summary

stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Pee Cee Cosma Sope Ltd has declared 30% dividend, ex-date: 19 Sep 25

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available

stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
14.70%
EBIT Growth (5y)
17.07%
EBIT to Interest (avg)
10.94
Debt to EBITDA (avg)
1.11
Net Debt to Equity (avg)
-0.38
Sales to Capital Employed (avg)
2.75
Tax Ratio
26.15%
Dividend Payout Ratio
8.26%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
21.35%
ROE (avg)
17.32%

Valuation key factors

Factor
Value
P/E Ratio
13
Industry P/E
44
Price to Book Value
1.98
EV to EBIT
7.98
EV to EBITDA
6.97
EV to Capital Employed
2.58
EV to Sales
0.54
PEG Ratio
NA
Dividend Yield
0.71%
ROCE (Latest)
31.70%
ROE (Latest)
14.88%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Mildly Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bearish
Dow Theory
No Trend
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Jun 2026stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 0 FIIs

Promoter with highest holding

Ankit Jain (9.44%)

Highest Public shareholder

None

Individual Investors Holdings

21.97%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'26 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Jun 2026 is 23.35% vs 0.25% in Jun 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Jun 2026 is 11.68% vs -13.13% in Jun 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Jun'26",
        "Jun'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "49.28",
          "val2": "39.95",
          "chgp": "23.35%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "3.69",
          "val2": "3.49",
          "chgp": "5.73%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.05",
          "val2": "0.02",
          "chgp": "150.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "3.25",
          "val2": "2.91",
          "chgp": "11.68%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "7.49%",
          "val2": "8.74%",
          "chgp": "-1.25%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Standalone) - Sep'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2025 is 2.34% vs 2.14% in Sep 2024",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": " Growth in half year ended Sep 2025 is -25.96% vs 21.66% in Sep 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "72.45",
          "val2": "70.79",
          "chgp": "2.34%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "5.46",
          "val2": "7.31",
          "chgp": "-25.31%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.03",
          "val2": "0.07",
          "chgp": "-57.14%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "4.45",
          "val2": "6.01",
          "chgp": "-25.96%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "7.54%",
          "val2": "10.33%",
          "chgp": "-2.79%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Standalone) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2025 is 8.92% vs 1.93% in Dec 2024",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2025 is -16.20% vs 15.78% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "114.47",
          "val2": "105.10",
          "chgp": "8.92%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "9.58",
          "val2": "11.53",
          "chgp": "-16.91%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.05",
          "val2": "0.16",
          "chgp": "-68.75%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "7.50",
          "val2": "8.95",
          "chgp": "-16.20%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "8.37%",
          "val2": "10.97%",
          "chgp": "-2.60%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'26",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2026 is 9.44% vs 8.01% in Mar 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2026 is -13.59% vs -7.66% in Mar 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "157.97",
          "val2": "144.34",
          "chgp": "9.44%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "12.66",
          "val2": "13.04",
          "chgp": "-2.91%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.09",
          "val2": "0.22",
          "chgp": "-59.09%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "8.33",
          "val2": "9.64",
          "chgp": "-13.59%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "8.01%",
          "val2": "9.03%",
          "chgp": "-1.02%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Jun'26 - YoYstock-summary

Jun'26
Jun'25
Change(%)
Net Sales
49.28
39.95
23.35%
Operating Profit (PBDIT) excl Other Income
3.69
3.49
5.73%
Interest
0.05
0.02
150.00%
Exceptional Items
0.00
0.00
Consolidate Net Profit
3.25
2.91
11.68%
Operating Profit Margin (Excl OI)
7.49%
8.74%
-1.25%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in quarter ended Jun 2026 is 23.35% vs 0.25% in Jun 2025

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Jun 2026 is 11.68% vs -13.13% in Jun 2025

Half Yearly Results Snapshot (Standalone) - Sep'25stock-summary

Sep'25
Sep'24
Change(%)
Net Sales
72.45
70.79
2.34%
Operating Profit (PBDIT) excl Other Income
5.46
7.31
-25.31%
Interest
0.03
0.07
-57.14%
Exceptional Items
0.00
0.00
Standalone Net Profit
4.45
6.01
-25.96%
Operating Profit Margin (Excl OI)
7.54%
10.33%
-2.79%
Values in Rs Cr.
Direction Arrows
Net Sales

Growth in half year ended Sep 2025 is 2.34% vs 2.14% in Sep 2024

Direction Arrows
Standalone Net Profit

Growth in half year ended Sep 2025 is -25.96% vs 21.66% in Sep 2024

Nine Monthly Results Snapshot (Standalone) - Dec'25stock-summary

Dec'25
Dec'24
Change(%)
Net Sales
114.47
105.10
8.92%
Operating Profit (PBDIT) excl Other Income
9.58
11.53
-16.91%
Interest
0.05
0.16
-68.75%
Exceptional Items
0.00
0.00
Standalone Net Profit
7.50
8.95
-16.20%
Operating Profit Margin (Excl OI)
8.37%
10.97%
-2.60%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2025 is 8.92% vs 1.93% in Dec 2024

Direction Arrows
Standalone Net Profit

YoY Growth in nine months ended Dec 2025 is -16.20% vs 15.78% in Dec 2024

Annual Results Snapshot (Consolidated) - Mar'26stock-summary

Mar'26
Mar'25
Change(%)
Net Sales
157.97
144.34
9.44%
Operating Profit (PBDIT) excl Other Income
12.66
13.04
-2.91%
Interest
0.09
0.22
-59.09%
Exceptional Items
0.00
0.00
Consolidate Net Profit
8.33
9.64
-13.59%
Operating Profit Margin (Excl OI)
8.01%
9.03%
-1.02%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2026 is 9.44% vs 8.01% in Mar 2025

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Mar 2026 is -13.59% vs -7.66% in Mar 2025

stock-summaryCompany CV
About Pee Cee Cosma Sope Ltd stock-summary
stock-summary
Pee Cee Cosma Sope Ltd
Micro Cap
FMCG
Pee Cee Cosma Sope Limited was incorporated in November, 1986 by a private Indian party. The Company is engaged in the business of Manufacturing of Laundry Soap, Detergent Powder and Cake operating in State of Uttar Pradesh, Rajasthan and Madhya Pradesh. Company became a public limited company in 1989 and its shares got listed on the Bombay Stock Exchange Ltd.
Company Coordinates stock-summary
Company Details
Padam Deep 5th Floor, G-10/8 Sanjay Place Agra Uttar Pradesh : 282002
stock-summary
Tel: 91-0562-2527332
stock-summary
pccosmalisting@doctorsoap.com
Registrar Details
Skyline Financial Services Pvt Ltd , D-153/A, 1st Floor, Okhla Industrial Area, Phase - I, New Delhi